Preferred method of communication
Research and teaching
Area of Focus
- Clinical outcomes in kidney and prostate cancer
Summary of Research
Dr. Bhindi has been extensively involved in clinical outcomes, health services, and translational research. His research interests include active surveillance, optimization of patient selection for local therapies, personalized medicine, and multimodal therapy for advanced and metastatic prostate and kidney cancer. To date, he has authored 42 peer-reviewed manuscripts, a textbook chapter (Diagnosis and Surgical Management of Renal Tumors), 12 editorials, and has presented his work at numerous national and international conferences with multiple best presentation/poster awards.
Dr. Bimal Bhindi is a urologic oncologist and a fellow of the Royal College of Physicians and Surgeons of Canada. After obtaining his medical degree at McGill University, he then completed residency training at the University of Toronto and obtained his Royal College Specialist certificate in Urology. During his residency training, he also completed the Royal College Clinical Investigator Program and obtained a Master’s degree in Clinical Epidemiology and Health Care Research. Following his residency, he completed urologic oncology fellowship training at Mayo Clinic (Rochester, MN, USA). He was subsequently recruited in 2018 to the Southern Alberta Institute of Urology and now focuses on all areas of urologic oncology, particularly prostate and kidney cancer.